Map for MDOverslag post-neoadjuvant post-operatief

Concept DECOR id DECOR effectiveDate FHIR id FHIR definition FHIR type
Demografische gegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.1 2017-03-30T15:30:34 onco-generic-dataelement-1 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-1 group
Patiƫnt 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.2 2017-03-30T15:30:34 onco-generic-dataelement-2 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-2 group
Naamgegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.3 2017-03-30T15:30:34 NL-CM-0.1.6 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.6 group
Initialen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.4 2017-03-30T15:30:34 NL-CM-0.1.35 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.35 string
Geslachtsnaam 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.5 2017-03-30T15:30:34 NL-CM-0.1.36 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.36 group
Achternaam 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.6 2017-03-30T15:30:34 NL-CM-0.1.24 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.24 string
PatientIdentificatienummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.7 2017-03-30T15:30:34 NL-CM-0.1.7 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.7 string
Geboortedatum 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.8 2017-03-30T15:30:34 NL-CM-0.1.10 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.10 dateTime
Geslacht 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.9 2017-03-30T15:30:34 NL-CM-0.1.9 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.9 choice
Zorgaanbieder 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.10 2017-03-30T15:30:34 NL-CM-17.2.1 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.1 group
ZorgaanbiederIdentificatieNummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.11 2017-03-30T15:30:34 NL-CM-17.2.2 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.2 string
OrganisatieNaam 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.12 2017-03-30T15:30:34 NL-CM-17.2.3 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.3 string
AfdelingSpecialisme 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.13 2017-03-30T15:30:34 NL-CM-17.2.7 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.7 choice
TelefoonEmail 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.14 2017-03-30T15:30:34 NL-CM-17.2.6 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.6 group
Contactgegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.15 2017-03-30T15:30:34 zib1bbr-dataelement-3414 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3414 group
Telefoonnummers 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.16 2017-03-30T15:30:34 zib1bbr-dataelement-3415 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3415 group
Telefoonnummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.17 2017-03-30T15:30:34 NL-CM-0.1.23 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.23 string
NummerSoort 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.18 2017-03-30T15:30:34 NL-CM-0.1.22 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.22 choice
EmailAdressen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.19 2017-03-30T15:30:34 zib1bbr-dataelement-3418 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3418 group
EmailAdres 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.20 2017-03-30T15:30:34 NL-CM-0.1.20 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.20 string
EmailSoort 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.21 2017-03-30T15:30:34 NL-CM-0.1.19 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.19 choice
Adres 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.22 2017-03-30T15:30:34 NL-CM-17.2.5 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.5 group
Adresgegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.23 2017-03-30T15:30:34 zib1bbr-dataelement-3421 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3421 group
Straat 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.24 2017-03-30T15:30:34 NL-CM-0.1.12 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.12 string
Huisnummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.25 2017-03-30T15:30:34 NL-CM-0.1.13 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.13 string
Huisnummerletter 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.26 2017-03-30T15:30:34 NL-CM-0.1.40 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.40 string
Huisnummertoevoeging 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.27 2017-03-30T15:30:34 NL-CM-0.1.41 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.41 string
AanduidingBijNummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.28 2017-03-30T15:30:34 NL-CM-0.1.42 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.42 choice
Postcode 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.29 2017-03-30T15:30:34 NL-CM-0.1.15 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.15 string
Woonplaats 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.30 2017-03-30T15:30:34 NL-CM-0.1.14 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.14 string
Gemeente 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.31 2017-03-30T15:30:34 NL-CM-0.1.16 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.16 string
Land 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.32 2017-03-30T15:30:34 NL-CM-0.1.17 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.17 choice
AdditioneleInformatie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.33 2017-03-30T15:30:34 NL-CM-0.1.28 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.28 string
AdresSoort 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.34 2017-03-30T15:30:34 NL-CM-0.1.11 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.11 choice
OrganisatieType 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.35 2017-03-30T15:30:34 NL-CM-17.2.4 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.4 choice
Multidisciplinair overleg 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.224 2017-03-30T15:30:34 onco-generic-dataelement-154 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-154 group
Datum MDO-verslag akkoord 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.225 2017-03-30T15:30:34 onco-generic-dataelement-155 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-155 date
Vraagstelling 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.226 2017-03-30T15:30:34 onco-generic-dataelement-156 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-156 string
Aanwezigheid: specialismen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.227 2017-03-30T15:30:34 onco-generic-dataelement-157 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-157 choice
Datum 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.229 2017-03-30T15:30:34 onco-generic-dataelement-160 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-160 date
Diagnose en stadiƫring 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.230 2017-03-30T15:30:34 onco-generic-dataelement-161 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-161 group
Mammacarcinoom 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.231 2017-03-30T15:30:34 onco-mamma-dataelement-231 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-231 group
Klinisch (cTNM) 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.246 2017-03-30T15:30:34 onco-mamma-dataelement-246 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-246 group
Lymfeklieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.260 2017-03-30T15:30:34 onco-mamma-dataelement-260 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-260 group
Klinisch positieve parasternale klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.264 2017-03-30T15:30:34 onco-mamma-dataelement-264 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-264 choice
Post-neoadjuvant Postoperatief (ypTNM) 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.334 2017-03-30T15:30:34 onco-mamma-dataelement-334 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-334 group
Tumor 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.335 2017-03-30T15:30:34 onco-mamma-dataelement-335 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-335 group
Zijdigheid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.336 2017-03-30T15:30:34 onco-mamma-dataelement-336 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-336 choice
Lokalisatie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.337 2017-03-30T15:30:34 onco-mamma-dataelement-337 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-337 choice
ypT-diameter 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.338 2017-03-30T15:30:34 onco-mamma-dataelement-338 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-338 quantity
ypT4-kenmerken 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.339 2017-03-30T15:30:34 onco-mamma-dataelement-339 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-339 choice
Morfologie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.340 2017-03-30T15:30:34 onco-mamma-dataelement-340 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-340 choice
Graad 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.341 2017-03-30T15:30:34 onco-mamma-dataelement-341 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-341 choice
Pathologische respons primaire tumor 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.342 2017-03-30T15:30:34 onco-mamma-dataelement-342 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-342 choice
Snijvlak 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.343 2017-03-30T15:30:34 onco-mamma-dataelement-343 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-343 choice
Angioinvasie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.344 2017-03-30T15:30:34 onco-mamma-dataelement-344 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-344 choice
ypT 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.345 2017-03-30T15:30:34 onco-mamma-dataelement-345 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-345 choice
Receptorstatus 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.346 2017-03-30T15:30:34 onco-mamma-dataelement-346 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-346 group
ER-percentage 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.347 2017-03-30T15:30:34 onco-mamma-dataelement-347 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-347 quantity
PR-percentage 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.348 2017-03-30T15:30:34 onco-mamma-dataelement-348 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-348 quantity
HER2-status 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.349 2017-03-30T15:30:34 onco-mamma-dataelement-349 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-349 choice
Lymfeklieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.350 2017-03-30T15:30:34 onco-mamma-dataelement-350 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-350 group
Zijdigheid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.351 2017-03-30T15:30:34 onco-mamma-dataelement-351 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-351 choice
Positieve supraclaviculaire klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.352 2017-03-30T15:30:34 onco-mamma-dataelement-352 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-352 choice
Positieve infraclaviculaire klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.353 2017-03-30T15:30:34 onco-mamma-dataelement-353 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-353 choice
Positieve parasternale klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.354 2017-03-30T15:30:34 onco-mamma-dataelement-354 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-354 choice
Aantal axillaire klieren met micro- en/of macrometastasen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.355 2017-03-30T15:30:34 onco-mamma-dataelement-355 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-355 integer
Aantal axillaire klieren met macrometastasen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.356 2017-03-30T15:30:34 onco-mamma-dataelement-356 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-356 integer
Aantal axillaire klieren met micrometastasen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.357 2017-03-30T15:30:34 onco-mamma-dataelement-357 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-357 integer
Extranodale groei SWK 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.359 2017-03-30T15:30:34 onco-mamma-dataelement-359 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-359 choice
Extranodale groei OKD 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.360 2017-03-30T15:30:34 onco-mamma-dataelement-360 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-360 choice
Topklier 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.361 2017-03-30T15:30:34 onco-mamma-dataelement-361 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-361 choice
ypN 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.362 2017-03-30T15:30:34 onco-mamma-dataelement-362 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-362 choice
Metastasen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.363 2017-03-30T15:30:34 onco-mamma-dataelement-363 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-363 group
ypM 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.364 2017-03-30T15:30:34 onco-mamma-dataelement-364 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-364 choice
ypTNM 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.365 2017-03-30T15:30:34 onco-mamma-dataelement-365 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-365 choice
Soort genmutatie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.366 2017-03-30T15:30:34 onco-mamma-dataelement-366 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-366 choice
Beleid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.382 2017-03-30T15:30:34 onco-generic-dataelement-163 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-163 group
Mammacarcinoom 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.383 2017-03-30T15:30:34 onco-mamma-dataelement-383 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-383 group
Surveillance 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.412 2017-03-30T15:30:34 onco-mamma-dataelement-412 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-412 group
Tijd verstreken sinds incidentiedatum 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.413 2017-03-30T15:30:34 onco-mamma-dataelement-413 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-413 quantity
Advies klinische studie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.414 2017-03-30T15:30:34 onco-generic-dataelement-164 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-164 choice
Klinische studie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.415 2017-03-30T15:30:34 onco-generic-dataelement-165 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-165 string
Beleid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.416 2017-03-30T15:30:34 onco-generic-dataelement-166 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-166 string
Motivatie afwijken richtlijn 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.417 2017-03-30T15:30:34 onco-generic-dataelement-168 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-168 choice
Motivatie afwijken richtlijn anders 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.418 2017-03-30T15:30:34 onco-generic-dataelement-169 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-169 string
Behandeling 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.419 2017-03-30T15:30:34 onco-generic-dataelement-171 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-171 group
Mammacarcinoom 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.420 2017-03-30T15:30:34 onco-mamma-dataelement-420 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-420 group
Chirurgie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.422 2017-03-30T15:30:34 onco-mamma-dataelement-422 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-422 group
Eerste re-excisie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.424 2017-03-30T15:30:34 onco-mamma-dataelement-424 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-424 choice
Operatie lymfeklieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.426 2017-03-30T15:30:34 onco-mamma-dataelement-426 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-426 choice